<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6819294/results/search/drug/results.xml">
  <result pre="suffered from severe mental disorders after receiving an overdose of" exact="acyclovir" post="and valacyclovir for the treatment of herpes zoster. The"/>
  <result pre="severe mental disorders after receiving an overdose of acyclovir and" exact="valacyclovir" post="for the treatment of herpes zoster. The literature review"/>
  <result pre="suggested that hemodialysis is better than peritoneal dialysis to clear" exact="acyclovir" post="from the circulation. The patient died after his consciousness"/>
  <result pre="to remove the drugs. Chronic renal failure Peritoneal dialysis Acyclovir" exact="Valacyclovir" post="Neurotoxicity Herpes zoster Case report Core tip: A patient"/>
  <result pre="drugs include valacyclovir, acyclovir, foscarnet, and bruvudin[2]. Compared with acyclovir," exact="valacyclovir" post="has advantages such as better oral effectiveness and tolerance,"/>
  <result pre="effectiveness and tolerance, high water solubility, and less adverse reactions." exact="Valacyclovir" post="rapidly transforms into acyclovir after entering the body. Its"/>
  <result pre="water solubility, and less adverse reactions. Valacyclovir rapidly transforms into" exact="acyclovir" post="after entering the body. Its common side effects include"/>
  <result pre="acyclovir[8]. The symptoms are possibly due to a metabolite of" exact="acyclovir" post="that is found at high levels in the cerebrospinal"/>
  <result pre="cerebrospinal fluid of patients with neuropsychiatric symptoms[10]. Since 90% of" exact="acyclovir" post="is cleared by the kidneys, patients with chronic kidney"/>
  <result pre="serum half-life of acyclovir[11]. Most patients with neuropsychiatric disorders under" exact="acyclovir" post="treatment have renal function impairment[10]. We present one patient"/>
  <result pre="with herpes zoster. He was given antiviral treatment with intravenous" exact="acyclovir" post="0.5 g qd and dexamethasone 5 mg qd to"/>
  <result pre="given antiviral treatment with intravenous acyclovir 0.5 g qd and" exact="dexamethasone" post="5 mg qd to relieve pain (continuous treatment for"/>
  <result pre="pain (continuous treatment for 3 d). The dermatologist prescribed oral" exact="valacyclovir" post="0.3 g bid after 3 d. Nonetheless, the patient"/>
  <result pre="3 d. Nonetheless, the patient misunderstood the recommendation, and received" exact="acyclovir" post="and valacyclovir simultaneously. After 2 d of treatment, the"/>
  <result pre="Nonetheless, the patient misunderstood the recommendation, and received acyclovir and" exact="valacyclovir" post="simultaneously. After 2 d of treatment, the local facial"/>
  <result pre="of hypertension for more than 10 years, under control using" exact="nifedipine" post="controlled release tablets 30 mg bid and valsartan 80"/>
  <result pre="control using nifedipine controlled release tablets 30 mg bid and" exact="valsartan" post="80 mg bid. He was diagnosed with idiopathic chronic"/>
  <result pre="mental disorders caused by antiviral drugs. TREATMENT Immediately after admission," exact="valacyclovir" post="was discontinued, the peritoneal fluid was increased to 5"/>
  <result pre="150-160/90 mmHg after antihypertensive treatment with Adalat 30 mg bid," exact="valsartan" post="80 mg bid and perindopril 8 mg qd. After"/>
  <result pre="with Adalat 30 mg bid, valsartan 80 mg bid and" exact="perindopril" post="8 mg qd. After 2 d of treatment, the"/>
  <result pre="on dialysis are at high risk of Herpes zoster. Both" exact="valacyclovir" post="and acyclovir are considered to have strong inhibitory effects"/>
  <result pre="are at high risk of Herpes zoster. Both valacyclovir and" exact="acyclovir" post="are considered to have strong inhibitory effects on types"/>
  <result pre="types 1 and 2 herpes virus and varicella herpes virus[12]." exact="Valacyclovir" post="is a precursor of acyclovir, which is converted to"/>
  <result pre="Valacyclovir is a precursor of acyclovir, which is converted to" exact="acyclovir" post="by the liver. Compared with acyclovir, it has the"/>
  <result pre="and pharmacodynamics, and lower frequency of use[5]. The neurotoxicity of" exact="acyclovir" post="was reported as early as the 1980s[6-9]. The clinical"/>
  <result pre="symptoms Outcome sex/age Pipili et al[18] 2013 Female/72 ESRD PD" exact="Valacyclovir" post="tablets 3 g daily for 3 d 3 d"/>
  <result pre="daily for 3 d 3 d Nifedipine, irbesartan, cinacalcet, atorvastatin," exact="alfacalcidol" post="Confusion and visual hallucinations 3 d, restored after PD"/>
  <result pre="per day Chaudhari et al[16] 2014 Male/66 ESRD PD Oral" exact="valacyclovir" post="1000 mg daily for 7 d 7 d Simvastatin,"/>
  <result pre="Asahi et al[17] 2009 Female/78 Without previous renal failure NO" exact="Valacyclovir" post="3000 mg/d 6 d Not mentioned Unconsciou-sness 5 d,"/>
  <result pre="14 d later Asahi et al[17] 2009 Male/73 ESRD Hemodialysis" exact="Valacyclovir" post="3000 mg/d 2 d Not mentioned Confusion, hallucination 2"/>
  <result pre="3 d later Singh et al[19] 2014 Female/58 ESRD HD" exact="Valacyclovir" post="500 mg/d 2 d Not mentioned Altered sensorium, irritability,"/>
  <result pre="d later Kambham-pati et al[20] 2011 Female/49 ESRD Maintenance hemodialysis" exact="Valacyclovir" post="1000 mg three times a day 2 d Not"/>
  <result pre="2017 Female/57 ESRD PD 1000 mg three times per day of" exact="valacyclovir" post="3 d Not mentioned Confusion and altered sensorium 1"/>
  <result pre="recovered 24 h later Izzedine et al[21] 2001 Female/60 ESRD PD" exact="Valacyclovir" post="500 mg daily Reduced 500 mg of valacyclovir every"/>
  <result pre="ESRD PD Valacyclovir 500 mg daily Reduced 500 mg of" exact="valacyclovir" post="every 2 d Not mentioned Disorientated with ocular and"/>
  <result pre="h later Strumia et al[22] 2004 Male/81 ESRD Hemodialysis Oral" exact="valacyclovir" post="1000 mg every 8 h then intravenous acyclovir in"/>
  <result pre="Hemodialysis Oral valacyclovir 1000 mg every 8 h then intravenous" exact="acyclovir" post="in full dosage 3 d Not mentioned Visual hallucination,"/>
  <result pre="et al[23] 1998 Male/58 CKD Intermittent hemodialysis twice a week" exact="Valacyclovir" post="3 g/d 2 d Not mentioned Dizziness, hallucinations, loss"/>
  <result pre="kidney disease; ESRD: End-stage renal disease; PD: Peritoneal dialysis. Since" exact="acyclovir" post="is mainly cleared by the kidneys, it is a"/>
  <result pre="recommended dose[11,24]. It is generally believed that a concentration of" exact="acyclovir" post="of 2.5-4.5 µg/mL[26] or a concentration of its main"/>
  <result pre="time still could not alleviate the clinical symptoms. Acyclovir and" exact="valacyclovir" post="are both soluble and low-protein-bound drugs. In terms of"/>
  <result pre="shown that in patients with normal renal function, 89% of" exact="valacyclovir" post="can be cleared from the urine in the form"/>
  <result pre="can be cleared from the urine in the form of" exact="acyclovir" post="after 2.5-3.3 h, while the half-life of the drug"/>
  <result pre="dialysis[21,27]. After a 6-h hemodialysis, the hemodialysis clearance rate of" exact="acyclovir" post="is up to 113 mL/min and the plasma drug"/>
  <result pre="who presented with hallucinations, dysarthria, and psychotic symptoms after intravenous" exact="acyclovir" post="with reduced dose, which further indicates that the dose"/>
  <result pre="with middle-and-large molecular weight or high protein binding rate. Meanwhile," exact="valacyclovir" post="and acyclovir are soluble and have a low protein"/>
  <result pre="molecular weight or high protein binding rate. Meanwhile, valacyclovir and" exact="acyclovir" post="are soluble and have a low protein binding rate,"/>
  <result pre="lack of literature on the efficacy of CRRT in clearing" exact="acyclovir" post="and valacyclovir. CONCLUSION In summary, clinicians need to be"/>
  <result pre="an evidence-based reviewArch Intern Med20081681137114418541820 6WadeJCMeyersJDNeurologic symptoms associated with parenteral" exact="acyclovir" post="treatment after marrow transplantationAnn Intern Med1983989219256305245 7CohenSMMinkoveJAZebleyJW3rdMulhollandJHSevere but reversible"/>
  <result pre="but reversible neurotoxicity from acyclovirAnn Intern Med1984100920 8TomsonCRGoodshipTHRodgerRSPsychiatric side-effects of" exact="acyclovir" post="in patients with chronic renal failureLancet19852385386 9VartianCVShlaesDMIntravenous acyclovir and"/>
  <result pre="side-effects of acyclovir in patients with chronic renal failureLancet19852385386 9VartianCVShlaesDMIntravenous" exact="acyclovir" post="and neurologic effectsAnn Intern Med198399568 10HelldénAOdar-CederlöfIDienerPBarkholtLMedinCSvenssonJOSäweJStåhleLHigh serum concentrations of"/>
  <result pre="and neurologic effectsAnn Intern Med198399568 10HelldénAOdar-CederlöfIDienerPBarkholtLMedinCSvenssonJOSäweJStåhleLHigh serum concentrations of the" exact="acyclovir" post="main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related"/>
  <result pre="observational studyNephrol Dial Transplant2003181135114112748346 11HaefeliWESchoenenbergerRAWeissPRitzRFAcyclovir-induced neurotoxicity: concentration-side effect relationship in" exact="acyclovir" post="overdoseAm J Med1993942122158430717 12LinWRLinHHLeeSSTsaiHCHuangCKWannSRChenYSChiangSCYenMYLiuYCComparative study of the efficacy and"/>
  <result pre="12LinWRLinHHLeeSSTsaiHCHuangCKWannSRChenYSChiangSCYenMYLiuYCComparative study of the efficacy and safety of valaciclovir versus" exact="acyclovir" post="in the treatment of herpes zosterJ Microbiol Immunol Infect20013413814211456360"/>
  <result pre="of the literatureEur J Neurol20091645746019187258 18PipiliCPanteliasKDedaETsiamalosPKostisEGrapsaEIntensification of peritoneal dialysis improves" exact="valacyclovir" post="neurotoxicityRen Fail20133528929023176110 19SinghNPShahHRAggarwalNJhaLKBehuraSValacyclovir associated neurotoxicity in a patient on"/>
  <result pre="can be effectively managed by hemodialysisEur J Neurol201118e3321087359 21IzzedineHMercadalLAymardGLaunay-VacherVMartinezVIssadBDerayGNeurotoxicity of" exact="valacyclovir" post="in peritoneal dialysis: a pharmacokinetic studyAm J Nephrol20012116216411359026 22StrumiaSDe"/>
  <result pre="peritoneal dialysis: a pharmacokinetic studyAm J Nephrol20012116216411359026 22StrumiaSDe MitriPBiondaENeurotoxicity of" exact="acyclovir" post="and valacyclovir in a hemodialyzed patientEur J Neurol200411686914692893 23Linssen-SchuurmansCDvan"/>
  <result pre="a pharmacokinetic studyAm J Nephrol20012116216411359026 22StrumiaSDe MitriPBiondaENeurotoxicity of acyclovir and" exact="valacyclovir" post="in a hemodialyzed patientEur J Neurol200411686914692893 23Linssen-SchuurmansCDvan KanEJFeithGWUgesDRNeurotoxicity caused"/>
  <result pre="in a hemodialyzed patientEur J Neurol200411686914692893 23Linssen-SchuurmansCDvan KanEJFeithGWUgesDRNeurotoxicity caused by" exact="valacyclovir" post="in a patient on hemodialysisTher Drug Monit1998203853869712461 24TakayanagiAMaehanaTKyodaYYanaseM[Neurotoxicity of"/>
  <result pre="valacyclovir in a patient on hemodialysisTher Drug Monit1998203853869712461 24TakayanagiAMaehanaTKyodaYYanaseM[Neurotoxicity of" exact="valacyclovir" post="in a peritoneal dialysis patient]Hinyokika Kiyo20105661761921187705 25SadjadiSARegmiSChauTAcyclovir Neurotoxicity in"/>
  <result pre="Pharmacokinetics of AcyclovirAm J Case Rep2018191459146230531673 26FeldmanSRodmanJGregoryBExcessive serum concentrations of" exact="acyclovir" post="and neurotoxicityJ Infect Dis19881573853883335815 27StathoulopoulouFDhillonSThodisHStathakisCVargemezisVEvaluation of valaciclovir dosage reduction"/>
  <result pre="hemodialysis therapyJpn J Clin Neurol200660581583 29KageyamaRHashizumeHNeurotoxicity induced by the recommended" exact="acyclovir" post="dosing in a dialysis patient with herpes zoster: A"/>
 </snippets>
</snippetsTree>
